Fig. 2 | Scientific Reports

Fig. 2

From: Clinical and molecular epidemiology of chikungunya outbreaks during 2019–2022 in India

Fig. 2

Clinical symptoms of chikungunya were recorded at the time of enrolment. (a) The proportions (0 to 1) of patients who presented with clinical symptoms are presented in a heatmap. The scale at the right top corner represents the proportion of patients with symptoms occurring in the increasing shade of orange (mildest shade: 0 and darkest shade: 1). (b) The proportions (0 to 1) of patients identified as reactive to the laboratory assays are presented in a heatmap. The scale at the right top corner represents the proportion of patients with symptoms occurring in the increasing shade of orange (mildest shade: 0 and darkest shade: 1). (c) The proportions (0 to 1) of patients identified with CHIKF categorically based on their socio-economic status are presented in a heatmap. The scale at the right top corner represents the proportion of patients with symptoms occurring in the increasing shade of orange (mildest shade: 0 and darkest shade: 1).

Back to article page